Page 32 - Demo

THE PHARMACY STATE OF THE INDUSTRY REPORT 31 Methodology Volume of sales is based on census data provided by IQVIA. The value of consumer health categories and products are then calculated by multiplying the total market sales by the average selling price from pharmacy. All sales are for the first quarter of 2019 compared with 2020. About NostraData Since 2010, NostraData has been a trusted partner to retail and hospital pharmacies, providing rich data and deep insights to its partners via innovative analytical platforms that focus customers on the most important aspects of their business opportunities. Questions about how we can help you can be directed to sales@nostradata.com.au. About IQVIA IQVIA (NYSE: IQV) is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Solutions are powered by the IQVIA CORE, which combines big data, advanced technology, analytics and extensive industry knowledge. Formed through the merger of IMS Health and Quintiles, IQVIA has about 55,000 employees worldwide. Learn more at iqvia.com. STATE OF THE INDUSTRY REPORT FORGET ‘UNPRECEDENTED’, THINK TIMES OF OPPORTUNITY ABy Mike Da Gama, Director, NostraData s I write this, we’re still in relative isolation, though restrictions are easing. There are challenging stories across the industry as community pharmacies, their families and suppliers all grapple with a new way of working, angry or fearful consumers, stock issues and wild swings in demand. Initially we saw a strong link between the number of global cases and Australian pharmacy sales, with people reacting to press and social media coverage by stockpiling and increased buying of COVID-19 related preventative products. Recently consumer health pharmacy sales have deteriorated overall by 25 per cent, following the trend of declining new coronavirus cases in Australia. Shopping centre and ‘destination’ pharmacies have seen a dramatic slowdown in sales post the rush on medication, toilet paper and sanitisers. • In the week ending May 2, 9.7 million items were scanned through Australian pharmacies. This equates to a 25 per cent decrease on the same week in 2019 and a 56 per cent decrease compared with the peak COVID-19 impacted week ending March 21, when 21.9 million units were sold. • It appears the decline has hit its lowest point as sales have begun to rally in recent weeks. • Since the outbreak of COVID-19 (January 19-May 2) more than 191 million units have been sold in TO PAG 32 Recommend Chemists’ Own® this winter www.chemistsown.com.au THIS MEDICINE MAY NOT BE RIGHT FOR YOU. ALWAYS READ THE LABEL BEFORE PURCHASE. FOLLOW THE DIRECTIONS FOR USE. INCORRECT USE COULD BE HARMFUL. IF SYMPTOMS PERSIST, TALK TO YOU HEALTH PROFESSIONAL. RETAIL PHARMACY • JUL 2020